Marwa M Abu-Serie, Fernanda Andrade, Patrícia Camára-Sánchez, Joaquin Seras-Franzoso, Diana Rafael, Zamira V Diaz-Riascos, Petra Gener, Ibane Abasolo, Simó Schwartz Jr.

Nanomedicine (Lond.) (Epub ahead of print)


Aim: Improving the stability and anti-cancer stem cell (CSC) activity of citral, a natural ALDH1A inhibitor. Materials & methods: Citral-loaded micelles (CLM) were obtained using Pluronic® F127 and its efficacy tested on the growth of four breast cancer cell lines. The impact of the CLM on the growth and functional hallmarks of breast CSCs were also evaluated using mammosphere and CSC reporter cell lines. Results: CLM improved the stability and growth inhibitory effects of citral. Importantly, CLM fully blocking the stemness features of CSCs (self-renewal, differentiation and migration) and in combination with paclitaxel CLM sensitized breast cancer cells to the chemotherapy. Conclusion: Targeting CSCs with CLM could improve the treatment of advanced breast cancer in combination with the standard chemotherapy.